SARNELLI, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 11.019
NA - Nord America 9.063
EU - Europa 7.950
SA - Sud America 1.248
AF - Africa 295
OC - Oceania 87
Continente sconosciuto - Info sul continente non disponibili 11
Totale 29.673
Nazione #
US - Stati Uniti d'America 8.655
SG - Singapore 4.749
RU - Federazione Russa 3.029
CN - Cina 2.069
VN - Vietnam 1.962
IT - Italia 1.870
BR - Brasile 1.011
HK - Hong Kong 877
DE - Germania 581
FR - Francia 484
FI - Finlandia 346
IE - Irlanda 331
UA - Ucraina 316
IN - India 272
JP - Giappone 262
GB - Regno Unito 254
NL - Olanda 234
CA - Canada 194
MX - Messico 144
SE - Svezia 106
PL - Polonia 99
BD - Bangladesh 92
AR - Argentina 86
PH - Filippine 86
KR - Corea 77
AU - Australia 76
ES - Italia 75
ID - Indonesia 73
ZA - Sudafrica 73
IQ - Iraq 70
TR - Turchia 67
CI - Costa d'Avorio 66
TH - Thailandia 54
PK - Pakistan 51
EC - Ecuador 47
SA - Arabia Saudita 37
TW - Taiwan 37
AT - Austria 34
CO - Colombia 27
BE - Belgio 25
LT - Lituania 24
MA - Marocco 24
VE - Venezuela 24
UZ - Uzbekistan 22
EG - Egitto 21
ET - Etiopia 20
RO - Romania 19
NP - Nepal 18
TN - Tunisia 18
MY - Malesia 17
CZ - Repubblica Ceca 16
GR - Grecia 16
IL - Israele 16
JO - Giordania 16
KE - Kenya 16
DZ - Algeria 15
AE - Emirati Arabi Uniti 14
PT - Portogallo 14
CL - Cile 13
PE - Perù 12
PY - Paraguay 12
AZ - Azerbaigian 11
NZ - Nuova Zelanda 11
RS - Serbia 11
IR - Iran 10
LB - Libano 10
TT - Trinidad e Tobago 10
JM - Giamaica 9
OM - Oman 9
UY - Uruguay 9
CR - Costa Rica 8
EU - Europa 8
HR - Croazia 7
PA - Panama 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
HN - Honduras 6
KZ - Kazakistan 6
MD - Moldavia 6
SN - Senegal 6
BO - Bolivia 5
BY - Bielorussia 5
MT - Malta 5
NI - Nicaragua 5
PR - Porto Rico 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
BB - Barbados 4
DK - Danimarca 4
GA - Gabon 4
LK - Sri Lanka 4
MK - Macedonia 4
AL - Albania 3
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
LU - Lussemburgo 3
MN - Mongolia 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
Totale 29.599
Città #
Singapore 2.238
San Jose 1.263
Hong Kong 843
Chandler 739
Moscow 735
Ashburn 587
Beijing 558
Ho Chi Minh City 498
Hanoi 439
Santa Clara 412
Naples 334
Jacksonville 314
Hefei 280
Millbury 263
The Dalles 258
Lauterbourg 250
Los Angeles 237
Tokyo 227
Princeton 206
Napoli 203
Nanjing 167
Council Bluffs 159
Dong Ket 156
Amsterdam 149
Munich 147
Boston 141
Buffalo 122
New York 114
Wilmington 106
Rome 102
São Paulo 100
Dallas 99
Dearborn 98
Des Moines 83
Houston 75
Warsaw 75
Redondo Beach 73
Da Nang 72
Frankfurt am Main 71
Milan 65
Menlo Park 64
Mexico City 64
Ottawa 63
Orem 61
Seattle 60
Turku 58
Woodbridge 57
Denver 56
Haiphong 56
London 54
Nanchang 52
Hebei 49
Lappeenranta 49
Seoul 49
Mumbai 47
Chennai 46
Dublin 46
Helsinki 44
Shenyang 44
Montreal 42
Nuremberg 41
Atlanta 40
Brooklyn 40
Boardman 37
Chicago 37
Tianjin 37
Kronberg 36
Lawrence 36
Falkenstein 34
Hải Dương 34
Stockholm 34
Poplar 32
Phoenix 31
Redwood City 31
Bangkok 30
Changsha 29
Johannesburg 29
Rio de Janeiro 29
Baghdad 27
Falls Church 27
Melbourne 27
Jakarta 26
Quito 26
Shanghai 26
Toronto 26
Pune 25
Guangzhou 24
Norwalk 24
Belo Horizonte 23
Can Tho 23
Jiaxing 23
Biên Hòa 22
Curitiba 22
San Francisco 21
Dhaka 20
Manchester 20
Thái Nguyên 20
Addis Ababa 19
Gateshead 19
Paris 19
Totale 15.245
Nome #
Effects of oral supplementation with the symbiotic (bifidobacterium longum w11 + fos actilight) on IBS with constipation: a randomized, dose finding trial, versus fibers, 549
La dispepsia post-infettiva: evoluzione sintomatologica- funzionale, predisposizione genetica, ruolo dell'Ossido Nitrico Sintetasi inducibile e coinvolgimento della glia entererica. 340
The potential of cannabidiol in the COVID‐19 pandemic. 240
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 228
ADHERENCE TO MEDITERRANEAN DIET AND IBS SYMPTOMS IN ADOLESCENTS 226
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 221
Effect of carbonated drinks on upper digestive tract sensations and physiology in healthy subjects. 206
Intrarectal Administration of Adelmidrol plus Hyaluronic Acid Gel Ameliorates Experimental Colitis in Mice and Inhibits Pro-Inflammatory Response in Ex Vivo Cultured Biopsies Derived from Ulcerative Colitis-Affected Patients 202
ALLELE-SPECIFIC TRANSCRIPTIONAL ACTIVITY OF THE VARIABLE NUMBER OF TANDEM REPEATS OF THE INDUCIBLE NITRIC OXIDE SYNTHASE GENE IS ASSOCIATED WITH IDIOPATHIC ACHALASIA 199
Sleeve gastrectomy-induced weight loss in severe obesity did not modify perception, intensity and pleasantness of basic tastes 196
Detection of colonic dysplasia in patients with ulcerative colitis using a targeted fluorescent peptide and confocal laser endomicroscopy: A pilot study 188
Clinical and nutritional correlates associated with weight changes in achalasia patients and the impact of laparoscopic Heller myotomy 161
SPECIFIC DYSPEPTIC SYMPTOMS ARE ASSOCIATED WITH POOR RESPONSE TO THERAPY IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 161
Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects ofL. casei DG® (Lactobacillus paracaseiCNCM I-1572) 161
Sweetened carbonated drinks do not alter upper digestive tract physiology in healthy subjects 157
Nasogastric tube after laparoscopic Heller-Dor surgery: Do you really need it? 155
The astroglial-derived S100 Beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. 155
Enteric Glia Stimulates Inflammation-Induced Responses in Human Intestine and Interacts with Immune Cells via S100B Protein 155
Altered taste perception in patients with gastroesophagealreflux disease 155
Oleoylethanolamide-producing Lactobacillus paracasei F19 improves metabolic and behavioral disorders by restoring intestinal permeability and microbiota-gut-brain axis in high-fat diet-induced obese male mice 154
EARLY CHANGES IN HRM-OESOPHAGEAL PARAMETERS IN PRE AND POST TREATMENT ACHALASIA PATIENTS 154
Partially hydrolyzed guar gum in the treatment of irritable bowel syndrome with constipation: effects of gender, age, and body mass index 152
Long-Term Functional Results of a Modified Caudal-to-Cranial Approach in Laparoscopic Segmental Left Colectomy for Diverticular Disease 151
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR-α-Dependent Inhibition of Akt/mTOR Pathway 150
Probiotic and Postbiotic Effects of Lactobacillus Casei DG on Enteroglial-Derived S100B and Nitric Oxide Production in Human Intestinal Biopsies 150
Preservation of the inferior mesenteric artery VS ligation of the inferior mesenteric artery in left colectomy: evaluation of functional outcomes-a prospective non-randomized controlled trial 149
Mild dehydration in dyspeptic athletes is able to increase gastrointestinal symptoms: Protective effects of an appropriate hydration 149
Impaired duodenal Palmitoylethanolamide release underlies acid-induced mast cells activation in Functional Dyspepsia 148
CHRONIC CONSTIPATION IS A RISK FACTOR FOR METABOLIC SYNDROME 147
S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. 145
Clinical correlation and disease phenotype in patients with esophageal achalasia and comorbid autoimmune diseases 145
Impaired post-reflux swallow-induced peristaltic wave in severe obesity and implication in esophageal hyposensitivity 144
Robotic versus laparoscopic approach to treat symptomatic achalasia: systematic review with meta-analysis 143
Eosinophilic esophagitis: From pathophysiology to treatment. 143
Rifaximin improves Clostridium difficile toxin A-induced toxicity in Caco-2 cells by the PXR-dependent TLR4/MyD88 /NF-?B pathway 143
Body position may change high resolution manometry parameters and drift therapeutic choice in achalasia patients 143
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice 143
Impact of psychological distress and psychophysical wellbeing on posttraumatic symptoms in parents of preterm infants after NICU discharge 142
Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells 141
Next-Generation Probiotics for Inflammatory Bowel Disease 140
TASTE DISORDERS IN PATIENTS WITH GASTROESOPHAGEALREFLUX DISEASE 140
HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia 140
Acetonic Extract from the Feijoa sellowiana Berg. Fruit Exerts Antioxidant Properties and Modulates Disaccharidases Activities in Human Intestinal Epithelial Cells 138
ACETONIC EXTRACT FROM FEIJOA SELLOWIANA BERG.FRUITS INHIBITS PROLIFERATION, MODULATES BRUSH BORDERMEMBRANE ENZYMES ACTIVITIES AND PREVENT LIPID PEROXIDATIONIN HUMAN INTESTINAL EPITHELIAL CELLS 138
Esophageal sensitivity and impaired post-reflux swallow-induced peristaltic wave are dependent by body mass index and acid exposition 138
N-Palmitoyl-D-Glucosamine Inhibits TLR-4/NLRP3 and Improves DNBS-Induced Colon Inflammation through a PPAR-α-Dependent Mechanism 136
Endoscopic treatment of esophageal achalasia 136
PHENYLTHIOCARBAMIDE TASTING STATUS AFFECTS QUININE-MEDIATED REDUCTION OF FOOD INTAKE 136
Effect of enteroglial-derived S100B protein on human peripheral and mucosal immune cells’ functions 135
GERD IS A PROTECTIVE RISK FACTOR FOR HYPERTENSION 135
Diet and functional dyspepsia: Clinical correlates and therapeutic perspectives 135
Effect of Dewaxed Coffee on Gastroesophageal Symptoms in Patients with GERD: A Randomized Pilot Study 134
Beneficial Effects on Exercise Capacity Associated with a Combination of Lactoferrin, Lysozyme, Lactobacillus, Resveratrol, Vitamins, and Oligoelements in Patients with Post-COVID-19 Syndrome: A Single-Center Retrospective Study 133
The bitter taste receptor agonist quinine reduces calorie intake and increases the postprandial release of cholecystokinin in healthy subjects 133
DOES STANDARDIZED DIET IMPROVE PROTON PUMP INHIBITOR RESPONSE IN GERD PATIENTS? 132
La proteina di derivazione enterogliale S100B stimola la produzione di ossido nitrico nella colite ulcerosa. 131
Postprandial Gastrointestinal Function Differs after Acute Administration of Sourdough Compared with Brewer's Yeast Bakery Products in Healthy Adults 131
CO2 modulates the central neural processing of sweet perception: an fMRI study 130
Enteric glia: A new player in inflammatory bowel diseases 130
Enteric Glial Protein S100b Up-Regulation Stimulates Nitric Oxide Production in Ulcerative Colitis. 129
CORRELATES TO ABDOMINAL PAIN IN CONSTIPATION PREVALENT IBS PATIENTS 129
Ketogal: A Derivative Ketorolac Molecule with Minor Ulcerogenic and Renal Toxicity 129
Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice 129
Nutraceuticals and Diet Supplements in Crohn's Disease: A General Overview of the Most Promising Approaches in the Clinic 129
Effect of enteroglial-derived S100B protein on proliferation and responses in human peripheral and mucosal immune cells 128
PPI general practitioners’prescribing in the treatment of acid-related disorders: the impact of generic PPI launch into the pharmaceutical market in Italy 128
THE MEDITERRANEAN DIET IS A PROTECTIVE FACTOR AGAINST GASTROINTESTINAL SYMPTOMS IN YOUNG PEOPLE 128
ACHALASIA TREATMENT IMPROVES SPECIFIC SYMPTOMS AND QUALITY OF LIFE: VALIDATION OF AN ACHALASIA SPECIFIC QUALITY OF LIFE QUESTIONNAIRE 128
Cortical representation of different taste modalities on the gustatory cortex: A pilot study 128
Esophageal Acid Exposure and Altered Neurocardiac Function in Patients with GERD and Idiopatic Cardiac Arrhythmias 127
6 months-treatment of symptomatic uncomplicated diverticular disease of the colon with Lactobacillus paracasei F19 127
THE ENTEROGLIAL DERIVED-S100B PROTEIN MEDIATES THEPROTECTIVE EFFECT OF LACTOBACILLUS CASEI DG ON LPS-INDUCEDNITRIC OXIDE PRODUCTION IN HUMAN INTESTINAL BIOPSIES 127
Autoimmune comorbidities in idiopathic achalasia 127
Genetic contribution to motility disorders of the upper gastrointestinal tract. 126
Proton pump inhibitors prescribing following the introduction of generic drugs 125
S100B Protein Stimulates Proliferation and Angiogenic Mediators Release through RAGE/pAkt/mTOR Pathway in Human Colon Adenocarcinoma Caco-2 Cells 124
Predictors of abdominal pain severity in patients with constipation-prevalent irritable bowel syndrome 123
Association between ccttt pentanucleotide repeat in the inducible nitric oxide synthase promoter polymorphism and achalasia 123
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 122
Laparoscopic Heller-Dor myotomy in elderly achalasia patients: a single center experience with PSM analysis 122
Gastro-duodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure 122
Irritable bowel syndrome and food interaction. 122
Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease 122
Oral Immunization with Escherichia coli Nissle 1917 Expressing SARS-CoV-2 Spike Protein Induces Mucosal and Systemic Antibody Responses in Mice 121
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway. 121
Lathyrus sativus diamine oxidase counteracts histamine-induced cell proliferation, migration and pro-angiogenic mediators release in human colon adenocarcinoma cell line Caco-2 121
Influenza dei farmaci generici sulle dinamiche prescrittive degli inibitori di pompa protonica in medicina generale 120
Palmitoylethanolamide Modulates Inflammation-Associated Vascular Endothelial Growth Factor (VEGF) Signaling via the Akt/mTOR Pathway in a Selective Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α)-Dependent Manner 120
I livelli tessutali di grelina non correlano con il tempo di svuotamento gastrico 119
PRESENCE OF ATYPICAL AND PAINFUL SYMPTOMS CORRELATES WITH LOW BMI AND POOR QUALITY OF LIFE IN GERD PATIENTS 119
Gastric determinants of maximum satiety induced by standardized solid and liquid meal. An MRI study in non obese healthy subjects 118
PARTIALLY HYDROLYZED GUAR GUM (PHGG) IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME (IBS) WITH CONSTIPATION: EFFECTS OF GENDER, AGE AND BODY MASS INDEX (BMI) 118
Sitagliptin versus saxagliptin in decompensated type 2 diabetes mellitus patients 118
Phytotherapics in COVID19: Why palmitoylethanolamide? 118
Role of Human Enteroglial Cells in Mediating Pathogenic and Probiotic Bacteria Effects on Intestinal Epithelial Cells 117
Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trial 117
Ultramicronized palmitoylethanolamide inhibits NLRP3 inflammasome expression and pro-inflammatory response activated by SARS-CoV-2 spike protein in cultured murine alveolar macrophages 117
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis 117
Author's reply: “Nutritional evaluations and post-treatment strategies in Achalasia” 116
A Multidisciplinary Approach for Type 2 Allergic Diseases: What Do Biologics Teach Us? 116
Totale 14.729
Categoria #
all - tutte 87.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021262 0 0 0 0 0 0 0 0 0 10 88 164
2021/20221.446 12 18 5 18 23 72 24 43 271 82 323 555
2022/20231.729 264 148 45 127 204 208 25 156 263 148 109 32
2023/20241.604 48 191 189 143 71 119 74 173 70 92 264 170
2024/20257.520 402 467 59 92 241 454 725 471 649 762 2.559 639
2025/202614.254 1.635 934 1.373 1.534 2.434 660 1.642 1.061 1.882 1.099 0 0
Totale 30.152